Increased systemic oxidative stress in patients with keratoconus

Purpose To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Methods Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched heal...

Full description

Saved in:
Bibliographic Details
Published inEye (London) Vol. 28; no. 3; pp. 285 - 289
Main Authors Toprak, I, Kucukatay, V, Yildirim, C, Kilic-Toprak, E, Kilic-Erkek, O
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2014
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0950-222X
1476-5454
1476-5454
DOI10.1038/eye.2013.262

Cover

Loading…
Abstract Purpose To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Methods Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. Results The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) ( P >0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls ( P =0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups ( P =0.497). Conclusions The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
AbstractList Purpose To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Methods Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. Results The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) ( P >0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls ( P =0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups ( P =0.497). Conclusions The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.PURPOSETo establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.METHODSTwenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497).RESULTSThe study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497).The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.CONCLUSIONSThe higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.
Author Kucukatay, V
Kilic-Toprak, E
Yildirim, C
Toprak, I
Kilic-Erkek, O
Author_xml – sequence: 1
  givenname: I
  surname: Toprak
  fullname: Toprak, I
  email: ibrahimt@doctor.com
  organization: Department of Ophthalmology, Servergazi State Hospital
– sequence: 2
  givenname: V
  surname: Kucukatay
  fullname: Kucukatay, V
  organization: Department of Physiology, Faculty of Medicine, Pamukkale University
– sequence: 3
  givenname: C
  surname: Yildirim
  fullname: Yildirim, C
  organization: Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Private Ege Akademi Eye Hospital
– sequence: 4
  givenname: E
  surname: Kilic-Toprak
  fullname: Kilic-Toprak, E
  organization: Department of Physiology, Faculty of Medicine, Pamukkale University
– sequence: 5
  givenname: O
  surname: Kilic-Erkek
  fullname: Kilic-Erkek, O
  organization: Department of Physiology, Faculty of Medicine, Pamukkale University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24310241$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1P3DAQxS0EKgvtjXMVqZceyNafcXJBVAgoElIvrdSb5dgTMM3ai-0A-9_j1QKiiJ5GmvnN05t5e2jbBw8IHRA8J5i132AFc4oJm9OGbqEZ4bKpBRd8G81wJ3BNKf2zi_ZSusG4DCX-gHYpZwRTTmbo-MKbCDqBrdIqZVg4U4UHZ3V2d1ClHCGlyvlqWRrgc6ruXb6u_kLUOZjgp_QR7Qx6TPDpqe6j32env05-1Jc_zy9Ovl_WRlCca6KFJpKxnnQD4daKXnRSENwXq2Jo254ZTixpNDGtFJRr03SgrTWtbTUfgO2jo43ucuoXYE0xE_WoltEtdFypoJ36d-LdtboKd4p1jWhxUwS-PgnEcDtBymrhkoFx1B7ClBQRWMpOMi4L-uUNehOm6Mt5a6ppMaZCFOrza0cvVp6fW4DDDWBiSCnC8IIQrNbZqZKdWmenSnYFp29w43J5e1jf48b_LdWbpVS0_RXEV1bf4x8BSraseQ
CitedBy_id crossref_primary_10_3928_01913913_20160831_01
crossref_primary_10_1167_iovs_18_24267
crossref_primary_10_61186_mlj_18_1_12
crossref_primary_10_1038_s41598_023_37472_8
crossref_primary_10_1016_j_jtos_2020_03_006
crossref_primary_10_1167_iovs_62_10_30
crossref_primary_10_3109_02713683_2015_1004717
crossref_primary_10_1080_09273948_2020_1741648
crossref_primary_10_1080_17469899_2024_2368801
crossref_primary_10_1167_iovs_66_2_60
crossref_primary_10_1097_OPX_0000000000001467
crossref_primary_10_3390_ijms23031255
crossref_primary_10_3390_nu14040913
crossref_primary_10_1111_ceo_14045
crossref_primary_10_1155_2017_9707650
crossref_primary_10_1016_j_jtos_2015_04_006
crossref_primary_10_1080_02713683_2017_1302592
crossref_primary_10_1111_aos_14714
crossref_primary_10_1194_jlr_M067264
crossref_primary_10_1097_ICO_0000000000000260
crossref_primary_10_3390_jcm13041168
crossref_primary_10_1111_ceo_13996
crossref_primary_10_1016_j_exer_2019_107897
crossref_primary_10_1080_02713683_2022_2025846
crossref_primary_10_1080_09273948_2019_1611876
crossref_primary_10_1016_j_joco_2019_06_003
crossref_primary_10_2147_OPTH_S301330
crossref_primary_10_1007_s10792_021_01949_0
crossref_primary_10_1007_s00438_016_1283_z
crossref_primary_10_12677_HJO_2022_111013
crossref_primary_10_1080_17469899_2022_2085557
crossref_primary_10_1097_ICL_0000000000000620
crossref_primary_10_1016_j_exer_2020_108211
crossref_primary_10_1097_ICO_0000000000000510
crossref_primary_10_1177_0006355X241290980
crossref_primary_10_3390_metabo13020187
crossref_primary_10_3390_pharmaceutics15030865
crossref_primary_10_1097_ICO_0000000000000878
crossref_primary_10_1167_tvst_13_9_13
crossref_primary_10_1038_s41433_019_0388_0
crossref_primary_10_6061_clinics_2015_10_02
crossref_primary_10_1038_s41598_018_33490_z
crossref_primary_10_1038_s41598_019_51502_4
crossref_primary_10_1097_ICO_0000000000003585
crossref_primary_10_1111_ceo_14215
crossref_primary_10_1080_09273948_2020_1817498
crossref_primary_10_1155_2020_9410952
crossref_primary_10_1167_iovs_63_5_12
crossref_primary_10_1186_s12886_022_02255_8
crossref_primary_10_3390_ijms24087437
crossref_primary_10_1038_eye_2015_63
crossref_primary_10_1155_2019_2453931
crossref_primary_10_1007_s10792_017_0672_6
crossref_primary_10_1177_11206721211000644
crossref_primary_10_1097_APO_0000000000000332
crossref_primary_10_1097_ICO_0000000000001018
crossref_primary_10_32604_mcb_2021_014071
crossref_primary_10_1038_s41598_017_13525_7
crossref_primary_10_1038_s41598_020_77122_x
crossref_primary_10_1007_s10792_020_01434_0
crossref_primary_10_1016_j_nurpra_2017_05_016
crossref_primary_10_4103_ijo_IJO_3403_20
crossref_primary_10_3390_biomedicines11020292
crossref_primary_10_1038_s41433_021_01753_1
crossref_primary_10_1155_2016_1243819
Cites_doi 10.1167/iovs.11-7732
10.1111/j.1755-3768.2011.02369.x
10.1016/j.clinbiochem.2003.10.014
10.1016/j.freeradbiomed.2008.07.021
10.1016/j.exer.2012.07.010
10.1016/j.clinbiochem.2005.08.008
10.1167/iovs.08-1969
10.1167/iovs.05-0828
10.1167/iovs.05-1500
10.1016/j.clinbiochem.2003.11.015
10.1097/00003226-199307000-00006
10.1167/iovs.04-0549
10.1097/ICL.0b013e31814fb64b
10.1016/0039-6257(84)90094-8
10.1167/iovs.04-1395
10.1186/1471-2334-6-114
10.1016/S0002-9394(03)00788-8
10.1016/S0039-6257(97)00119-7
10.1177/112067210001000305
10.1177/002215540205000306
ContentType Journal Article
Copyright Royal College of Ophthalmologists 2014
Copyright Nature Publishing Group Mar 2014
Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists
Copyright_xml – notice: Royal College of Ophthalmologists 2014
– notice: Copyright Nature Publishing Group Mar 2014
– notice: Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/eye.2013.262
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest Central Student
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Increased systemic oxidative stress in keratoconus
EISSN 1476-5454
EndPage 289
ExternalDocumentID PMC3965806
3244737451
24310241
10_1038_eye_2013_262
Genre Journal Article
GroupedDBID ---
-Q-
.GJ
0R~
29G
2WC
36B
39C
3O-
4.4
406
53G
5RE
6PF
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABFSG
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFFNX
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ATHPR
AXYYD
AYFIA
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
E3Z
EBLON
EBS
EBX
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
L7B
M1P
M7P
NQJWS
O9-
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c520t-1a5a1733b19f14dd5b597510b5455f88b3c41d16a1c87524ac69eaddc8d8a4fe3
IEDL.DBID BENPR
ISSN 0950-222X
1476-5454
IngestDate Thu Aug 21 13:42:32 EDT 2025
Thu Sep 04 17:26:52 EDT 2025
Fri Jul 25 09:04:23 EDT 2025
Mon Jul 21 06:05:50 EDT 2025
Tue Jul 01 03:00:22 EDT 2025
Thu Apr 24 23:03:12 EDT 2025
Mon Jul 21 06:08:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords keratoconus
antioxidant status
oxidant status
oxidative stress
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-1a5a1733b19f14dd5b597510b5455f88b3c41d16a1c87524ac69eaddc8d8a4fe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/eye2013262.pdf
PMID 24310241
PQID 1506800255
PQPubID 33647
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3965806
proquest_miscellaneous_1507797347
proquest_journals_1506800255
pubmed_primary_24310241
crossref_primary_10_1038_eye_2013_262
crossref_citationtrail_10_1038_eye_2013_262
springer_journals_10_1038_eye_2013_262
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle The Scientific Journal of The Royal College of Ophthalmologists
PublicationTitle Eye (London)
PublicationTitleAbbrev Eye
PublicationTitleAlternate Eye (Lond)
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Horoz, Bolukbas, Bolukbas, Aslan, Koylu, Selek (CR20) 2006; 6
Kenney, Chwa, Atilano, Tran, Carballo, Saghizadeh (CR19) 2005; 46
Balasubramanian, Mohan, Pye, Willcox (CR24) 2012; 90
Arnal, Peris-Martínez, Menezo, Johnsen-Soriano, Romero (CR5) 2011; 52
Behndig, Karlsson, Johansson, Brannstrom, Marklund (CR8) 2001; 42
Smith, Easty (CR18) 2000; 10
Chwa, Atilano, Hertzog, Zheng, Langberg, Kim (CR16) 2008; 49
Saijyothi, Fowjana, Madhumathi, Rajeshwari, Thennarasu, Prema (CR23) 2012; 103
Buddi, Lin, Atilano, Zorapapel, Kenney, Brown (CR4) 2002; 50
Ferreira, Lerner, Brunzini, Evelson, Llesuy (CR11) 2004; 137
Rabinowitz (CR1) 1998; 42
Monnies (CR3) 2007; 33
Chwa, Atilano, Reddy, Jordan, Kim, Kenney (CR15) 2006; 47
Gondhowiardjo, van Haeringen (CR17) 1993; 12
Erel (CR10) 2004; 37
Harma, Harma, Erel (CR13) 2003; 133
Atilano, Coskun, Chwa, Jordan, Reddy, Le (CR14) 2005; 46
Shoham, Hadziahmetovic, Dunaief, Mydlarski, Schipper (CR7) 2008; 45
Zhou, Sawaguchi, Twining, Sugar, Feder, Yue (CR9) 1998; 39
Udar, Atilano, Brown, Holguin, Small, Nesburn (CR21) 2006; 47
Kenney, Brown, Rajeev (CR6) 2000; 26
Krachmer, Feder, Belin (CR2) 1984; 28
Erel (CR22) 2004; 37
Erel (CR12) 2005; 38
E Arnal (BFeye2013262_CR5) 2011; 52
MC Kenney (BFeye2013262_CR19) 2005; 46
YS Rabinowitz (BFeye2013262_CR1) 1998; 42
JH Krachmer (BFeye2013262_CR2) 1984; 28
TD Gondhowiardjo (BFeye2013262_CR17) 1993; 12
M Horoz (BFeye2013262_CR20) 2006; 6
O Erel (BFeye2013262_CR12) 2005; 38
SA Balasubramanian (BFeye2013262_CR24) 2012; 90
L Zhou (BFeye2013262_CR9) 1998; 39
O Erel (BFeye2013262_CR22) 2004; 37
A Shoham (BFeye2013262_CR7) 2008; 45
AV Saijyothi (BFeye2013262_CR23) 2012; 103
MC Kenney (BFeye2013262_CR6) 2000; 26
A Behndig (BFeye2013262_CR8) 2001; 42
O Erel (BFeye2013262_CR10) 2004; 37
CW Monnies (BFeye2013262_CR3) 2007; 33
M Chwa (BFeye2013262_CR16) 2008; 49
SR Atilano (BFeye2013262_CR14) 2005; 46
VA Smith (BFeye2013262_CR18) 2000; 10
N Udar (BFeye2013262_CR21) 2006; 47
R Buddi (BFeye2013262_CR4) 2002; 50
SM Ferreira (BFeye2013262_CR11) 2004; 137
M Chwa (BFeye2013262_CR15) 2006; 47
M Harma (BFeye2013262_CR13) 2003; 133
11850437 - J Histochem Cytochem. 2002 Mar;50(3):341-51
22960318 - Exp Eye Res. 2012 Oct;103:41-6
18718524 - Free Radic Biol Med. 2008 Oct 15;45(8):1047-55
15003729 - Clin Biochem. 2004 Apr;37(4):277-85
22413749 - Acta Ophthalmol. 2012 Jun;90(4):e303-9
15728537 - Invest Ophthalmol Vis Sci. 2005 Mar;46(3):823-32
16877401 - Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3345-51
14691728 - Swiss Med Wkly. 2003 Nov 1;133(41-42):563-6
8339559 - Cornea. 1993 Jul;12(4):310-4
18515575 - Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4361-9
14700645 - Am J Ophthalmol. 2004 Jan;137(1):62-9
16214125 - Clin Biochem. 2005 Dec;38(12):1103-11
16842626 - BMC Infect Dis. 2006;6:114
10656302 - CLAO J. 2000 Jan;26(1):10-3
6230745 - Surv Ophthalmol. 1984 Jan-Feb;28(4):293-322
14725941 - Clin Biochem. 2004 Feb;37(2):112-9
9620070 - Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1117-24
16638997 - Invest Ophthalmol Vis Sci. 2006 May;47(5):1902-10
11071029 - Eur J Ophthalmol. 2000 Jul-Sep;10(3):215-26
11527942 - Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2293-6
17993819 - Eye Contact Lens. 2007 Nov;33(6 Pt 1):265-71
9493273 - Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319
15790887 - Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1256-63
21969298 - Invest Ophthalmol Vis Sci. 2011;52(12):8592-7
References_xml – volume: 52
  start-page: 8592
  year: 2011
  end-page: 8597
  ident: CR5
  article-title: Oxidative stress in keratoconus?
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-7732
– volume: 90
  start-page: e303
  year: 2012
  end-page: e309
  ident: CR24
  article-title: Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2011.02369.x
– volume: 39
  start-page: 1117
  year: 1998
  end-page: 1124
  ident: CR9
  article-title: Expression of degradative enzymes and protease inhibitors in corneas with keratoconus
  publication-title: Invest Ophthalmol Vis Sci
– volume: 37
  start-page: 112
  year: 2004
  end-page: 119
  ident: CR10
  article-title: A novel automated method to measure total antioxidant response against potent free radical reactions
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2003.10.014
– volume: 45
  start-page: 1047
  year: 2008
  end-page: 1055
  ident: CR7
  article-title: Oxidative stress in diseases of the human cornea
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2008.07.021
– volume: 103
  start-page: 41
  year: 2012
  end-page: 46
  ident: CR23
  article-title: Tear fluid small molecular antioxidants profiling shows lowered glutathione in keratoconus
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2012.07.010
– volume: 38
  start-page: 1103
  year: 2005
  end-page: 1111
  ident: CR12
  article-title: A new automated colorimetric method for measuring total oxidant status
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2005.08.008
– volume: 49
  start-page: 4361
  year: 2008
  end-page: 4369
  ident: CR16
  article-title: Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-1969
– volume: 47
  start-page: 1902
  year: 2006
  end-page: 1910
  ident: CR15
  article-title: Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0828
– volume: 47
  start-page: 3345
  year: 2006
  end-page: 3351
  ident: CR21
  article-title: SOD1: a candidate gene for keratoconus
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-1500
– volume: 42
  start-page: 2293
  year: 2001
  end-page: 2296
  ident: CR8
  article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea
  publication-title: Invest Ophthalmol Vis Sci
– volume: 37
  start-page: 277
  year: 2004
  end-page: 285
  ident: CR22
  article-title: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2003.11.015
– volume: 12
  start-page: 310
  year: 1993
  end-page: 314
  ident: CR17
  article-title: Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione s-transferase in pathologic corneas
  publication-title: Cornea
  doi: 10.1097/00003226-199307000-00006
– volume: 46
  start-page: 823
  year: 2005
  end-page: 832
  ident: CR19
  article-title: Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-0549
– volume: 33
  start-page: 265
  year: 2007
  end-page: 271
  ident: CR3
  article-title: Abnormal rubbing and keractectasia
  publication-title: Eye Contact Lens
  doi: 10.1097/ICL.0b013e31814fb64b
– volume: 28
  start-page: 293
  year: 1984
  end-page: 322
  ident: CR2
  article-title: Keratoconus and related noninflammatory corneal thinning disorders
  publication-title: Surv Ophthalmol
  doi: 10.1016/0039-6257(84)90094-8
– volume: 46
  start-page: 1256
  year: 2005
  end-page: 1263
  ident: CR14
  article-title: Accumulation of mitochondrial DNA damage in keratoconus corneas
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-1395
– volume: 6
  start-page: 114
  year: 2006
  ident: CR20
  article-title: Oxidative stress in hepatitis C infected end-stage renal disease subjects
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-6-114
– volume: 133
  start-page: 563
  year: 2003
  end-page: 566
  ident: CR13
  article-title: Increased oxidative stress in patients with hydatidiform mole
  publication-title: Swiss Med Wkly
– volume: 137
  start-page: 62
  year: 2004
  end-page: 69
  ident: CR11
  article-title: Oxidative stress markers in aqueous humor of glaucoma patients
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(03)00788-8
– volume: 42
  start-page: 297
  year: 1998
  end-page: 319
  ident: CR1
  article-title: Keratoconus
  publication-title: Surv Ophthalmol
  doi: 10.1016/S0039-6257(97)00119-7
– volume: 26
  start-page: 10
  year: 2000
  end-page: 13
  ident: CR6
  article-title: Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis
  publication-title: CLAO J
– volume: 10
  start-page: 215
  year: 2000
  end-page: 226
  ident: CR18
  article-title: Matrix metalloproteinase 2: involvement in keratoconus
  publication-title: Eur J Ophthalmol
  doi: 10.1177/112067210001000305
– volume: 50
  start-page: 341
  year: 2002
  end-page: 351
  ident: CR4
  article-title: Evidence of oxidative stress in human corneal diseases
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540205000306
– volume: 45
  start-page: 1047
  year: 2008
  ident: BFeye2013262_CR7
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2008.07.021
– volume: 103
  start-page: 41
  year: 2012
  ident: BFeye2013262_CR23
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2012.07.010
– volume: 52
  start-page: 8592
  year: 2011
  ident: BFeye2013262_CR5
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-7732
– volume: 46
  start-page: 1256
  year: 2005
  ident: BFeye2013262_CR14
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-1395
– volume: 10
  start-page: 215
  year: 2000
  ident: BFeye2013262_CR18
  publication-title: Eur J Ophthalmol
  doi: 10.1177/112067210001000305
– volume: 47
  start-page: 1902
  year: 2006
  ident: BFeye2013262_CR15
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0828
– volume: 46
  start-page: 823
  year: 2005
  ident: BFeye2013262_CR19
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-0549
– volume: 33
  start-page: 265
  year: 2007
  ident: BFeye2013262_CR3
  publication-title: Eye Contact Lens
  doi: 10.1097/ICL.0b013e31814fb64b
– volume: 26
  start-page: 10
  year: 2000
  ident: BFeye2013262_CR6
  publication-title: CLAO J
– volume: 38
  start-page: 1103
  year: 2005
  ident: BFeye2013262_CR12
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2005.08.008
– volume: 37
  start-page: 277
  year: 2004
  ident: BFeye2013262_CR22
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2003.11.015
– volume: 42
  start-page: 297
  year: 1998
  ident: BFeye2013262_CR1
  publication-title: Surv Ophthalmol
  doi: 10.1016/S0039-6257(97)00119-7
– volume: 39
  start-page: 1117
  year: 1998
  ident: BFeye2013262_CR9
  publication-title: Invest Ophthalmol Vis Sci
– volume: 47
  start-page: 3345
  year: 2006
  ident: BFeye2013262_CR21
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-1500
– volume: 137
  start-page: 62
  year: 2004
  ident: BFeye2013262_CR11
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(03)00788-8
– volume: 42
  start-page: 2293
  year: 2001
  ident: BFeye2013262_CR8
  publication-title: Invest Ophthalmol Vis Sci
– volume: 49
  start-page: 4361
  year: 2008
  ident: BFeye2013262_CR16
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-1969
– volume: 50
  start-page: 341
  year: 2002
  ident: BFeye2013262_CR4
  publication-title: J Histochem Cytochem
  doi: 10.1177/002215540205000306
– volume: 6
  start-page: 114
  year: 2006
  ident: BFeye2013262_CR20
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-6-114
– volume: 133
  start-page: 563
  year: 2003
  ident: BFeye2013262_CR13
  publication-title: Swiss Med Wkly
– volume: 37
  start-page: 112
  year: 2004
  ident: BFeye2013262_CR10
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2003.10.014
– volume: 28
  start-page: 293
  year: 1984
  ident: BFeye2013262_CR2
  publication-title: Surv Ophthalmol
  doi: 10.1016/0039-6257(84)90094-8
– volume: 12
  start-page: 310
  year: 1993
  ident: BFeye2013262_CR17
  publication-title: Cornea
  doi: 10.1097/00003226-199307000-00006
– volume: 90
  start-page: e303
  year: 2012
  ident: BFeye2013262_CR24
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2011.02369.x
– reference: 15728537 - Invest Ophthalmol Vis Sci. 2005 Mar;46(3):823-32
– reference: 11850437 - J Histochem Cytochem. 2002 Mar;50(3):341-51
– reference: 6230745 - Surv Ophthalmol. 1984 Jan-Feb;28(4):293-322
– reference: 16638997 - Invest Ophthalmol Vis Sci. 2006 May;47(5):1902-10
– reference: 16214125 - Clin Biochem. 2005 Dec;38(12):1103-11
– reference: 22960318 - Exp Eye Res. 2012 Oct;103:41-6
– reference: 15003729 - Clin Biochem. 2004 Apr;37(4):277-85
– reference: 14725941 - Clin Biochem. 2004 Feb;37(2):112-9
– reference: 16842626 - BMC Infect Dis. 2006;6:114
– reference: 9620070 - Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1117-24
– reference: 18718524 - Free Radic Biol Med. 2008 Oct 15;45(8):1047-55
– reference: 8339559 - Cornea. 1993 Jul;12(4):310-4
– reference: 16877401 - Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3345-51
– reference: 14700645 - Am J Ophthalmol. 2004 Jan;137(1):62-9
– reference: 17993819 - Eye Contact Lens. 2007 Nov;33(6 Pt 1):265-71
– reference: 18515575 - Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4361-9
– reference: 15790887 - Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1256-63
– reference: 14691728 - Swiss Med Wkly. 2003 Nov 1;133(41-42):563-6
– reference: 10656302 - CLAO J. 2000 Jan;26(1):10-3
– reference: 11527942 - Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2293-6
– reference: 9493273 - Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319
– reference: 11071029 - Eur J Ophthalmol. 2000 Jul-Sep;10(3):215-26
– reference: 21969298 - Invest Ophthalmol Vis Sci. 2011;52(12):8592-7
– reference: 22413749 - Acta Ophthalmol. 2012 Jun;90(4):e303-9
SSID ssj0014770
Score 2.3439534
Snippet Purpose To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total...
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 285
SubjectTerms 692/420
692/699/3161
Adult
Antioxidants - metabolism
Biomarkers - blood
Clinical Study
Female
Humans
Keratoconus - blood
Keratoconus - etiology
Keratoconus - physiopathology
Laboratory Medicine
Male
Medicine
Medicine & Public Health
Ophthalmology
Oxidants - blood
Oxidative Stress - physiology
Pharmaceutical Sciences/Technology
Surgery
Surgical Oncology
Title Increased systemic oxidative stress in patients with keratoconus
URI https://link.springer.com/article/10.1038/eye.2013.262
https://www.ncbi.nlm.nih.gov/pubmed/24310241
https://www.proquest.com/docview/1506800255
https://www.proquest.com/docview/1507797347
https://pubmed.ncbi.nlm.nih.gov/PMC3965806
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9wwDBbrFcpexra2W7Zb8WDtS0kbx3bsPO0XV8pgZZQW7i04tkOPjaTt3cH23092fOlu7fYckRjJsj5ZyieAdwUvmRWapbyWLuVaoEthHpTmXKIzYUxzdWD7PCtOL_mXqZjGC7d5bKtcnYnhoLad8Xfkx54JTwUE_P76JvVTo3x1NY7Q2IBNPIKVGMHmp8nZt_OhjsBlGBeHOCJLMRJOY-t7xtSx--VZMik7yot8PSjdQ5r3Gyb_qpqGYHTyFJ5EFEk-9mZ_Bo9c-xy2vsY6-TZ8QLf33ebOkp6qeWZI93NmA8s36f8PIbOWRFbVOfHXseS7J1juMEFeznfg8mRy8fk0jbMSUiPybJFSLTSVjNW0bCi3VtSYKaC_1YiQRKNUzQynlhaaGsxQcq5NUeImskZZpXnj2C6M2q51L4FIVXAtndYNrbmwUuN7RO5Ko_KGapUlcLhSVmUikbifZ_GjCgVtpipUbeVVW6FqE9gfpK97Ao1_yI1Xeq-iG82rO6Mn8HZ4jA7gqxq6dd0yyEhZSsZlAi96Mw0fyhEeIQihCcg1Aw4Cnlx7_Uk7uwok28yz4mRFAgcrU_-xrAfW_-r_638Nj1GS991rYxgtbpfuDcKZRb0HG3Iq9-LO_Q3fXvXV
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiDeBAkaiXFDa-BU7B8Sz1Za2K4RaaW_BsR11VZQUdlfQP8VvZJwXLAVuPdtxrHnYnz3jbwCepiLjThoei0L5WBiJLoXnoJgJhc6Ee5ovGrbPcTo6Eu8ncrICP_q3MCGtsl8Tm4Xa1TbckW8FJjzdIOCXp1_iUDUqRFf7EhqtWez5s294ZJu92H2H-t1gbGf78O0o7qoKxFayZB5TIw1VnBc0K6lwThaIqdEyC8QSstS64FZQR1NDLWJ5JoxNMxS3s9ppI0rPcdxLsIYwI0MvWnuzPf7wcYhbCNWUp0PcksS48066VPuE6y1_Flg5Kd9kKVveBM8h2_MJmn9EaZvNb-c6XOtQK3ndmtkNWPHVTbh80MXlb8ErXGZCdrt3pKWGnlpSf5-6hlWctO9RyLQiHYvrjITrX3ISCJ1rPJAvZrfh6EKkeAdWq7ry94AonQqjvDElLYR0yuA4kvnMalZSo5MInvfCym1HXB7qZ3zOmwA61zmKNg-izVG0EWwMvU9bwo5_9Fvv5Z53bjvLfxlZBE-GZnS4EEUxla8XTR-lMsWFiuBuq6bhRwzhGIIeGoFaUuDQIZB5L7dU0-OG1JsHFp4kjeBZr-rfpvWX-d____wfw5XR4cF-vr873nsAV_Er0WbOrcPq_OvCP0QoNS8edfZL4NNFu8xP8oEyAA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbwJFDAS5YLCxq_YOSBe7aqlsKoQlfYWnNgRK1BS2F1B_xq_jnHiBJYCt57tONZ4xvPZM_4G4GEqMm6l4bEolIuFkWhSeA6KmVBoTOjTXNGyfU7T_WPxeiZnG_Cjfwvj0yr7PbHdqG1T-jvysWfC0y0CHlchLeJod_Ls5EvsK0j5SGtfTqNTkUN3-g2Pb4unB7u41juMTfbev9qPQ4WBuJQsWcbUSEMV5wXNKiqslQXia9TSAnGFrLQueCmopamhJeJ6JkyZZih6W2qrjagcx3EvwKZCr6hHsPlyb3r0bohhCNWWqkMMk8TohWch7T7heuxOPUMn5U9YytYd4hmUezZZ84-IbesIJ5fhUkCw5EWncldgw9VXYettiNFfg-e45fhMd2dJRxM9L0nzfW5bhnHSvU0h85oERtcF8VfB5JMnd27wcL5aXIfjc5HiDRjVTe1uAVE6FUY5YypaCGmVwXEkc1mpWUWNTiJ43AsrLwOJua-l8Tlvg-lc5yja3Is2R9FGsDP0PunIO_7Rb7uXex5MeJH_UrgIHgzNaHw-omJq16zaPkpligsVwc1umYYfMYRmCIBoBGptAYcOnth7vaWef2wJvrln5EnSCB71S_3btP4y_9v_n_992EJTyd8cTA_vwEX8SHRJdNswWn5dubuIqpbFvaC-BD6ct8X8BOr6Niw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+systemic+oxidative+stress+in+patients+with+keratoconus&rft.jtitle=Eye+%28London%29&rft.au=Toprak%2C+I&rft.au=Kucukatay%2C+V&rft.au=Yildirim%2C+C&rft.au=Kilic-Toprak%2C+E&rft.date=2014-03-01&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=28&rft.issue=3&rft.spage=285&rft.epage=289&rft_id=info:doi/10.1038%2Feye.2013.262&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_eye_2013_262
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon